semaglutide nasal spray (WL1006)
/ Shanghai World Leader Pharmaceutical
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
March 13, 2026
A Clinical Study of Semaglutide Nasal Spray in Overweight or Obese Adults
(clinicaltrials.gov)
- P1 | N=60 | Recruiting | Sponsor: Shanghai World Leader Pharmaceutical Co., Ltd.
New P1 trial • Genetic Disorders • Obesity
1 to 1
Of
1
Go to page
1